Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
In contrast, another trial in 409 women with breast cancer found that ALCAR (3 g/day for 24 weeks) increased anticancer drug (taxanes)-induced peripheral neuropathy and decreased measures of functional status compared to placebo (91)
So the honest framing is: a well-founded, biologically plausible combination that many clinicians use, but not one backed by the kind of definitive randomized evidence that would let anyone promise a result
The treatment lasted 8 weeks
Wide Product Range: Apart from neurological products, we have a broad portfolio across multiple therapeutic segments
Adverse reactions Reactions to drugs encompass a broad range of responses to medications, including drug allergy rashes
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
